The Impact of Late Effects After Treatment for Bladder Cancer on Quality of Life

NCT05195515 · tracked via the Priya Life Science Denmark tracker

Sponsor

Aarhus University Hospital

Phase

Observational

Started

2022-01-01

Last updated

2026-03-03

Condition(s) studied

Bladder Cancer

Study summary

Bladder Cancer prognosis, treatment, and subsequent morbidity and mortality vary between the different stages, thus resulting in a different impact on patients' lives. There are some well known late effects of the treatments for bladder cancer, but the knowledge of their impact on patients Quality of Life is sparse. This study aims to determine the prevalence of late effects impact on Quality of Life and potential risk factors for impairment.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Patients are eligible if they are referred to a hospital in the Central Region Denmark, due to hematuria between 01/01/2022 and 01/01/2023 * Ability to understand written and oral Danish Exclusion Criteria: * Known Alzheimers disease * Diagnosed other causes explaining the hematuria

Primary outcome measure(s)

Health-related Quality of Life — 5 years from baseline inclusion
Changes in Quality of Life measured using validated instruments

Trial sites (5)

Facility	City	Region
Department of Urology, Aarhus University Hospital	Aarhus N	Denmark
Department of Urology, Regional Hospital Gødstrup	Gødstrup	Denmark
Department of Urology, Regional Hospital Horsens	Horsens	Denmark
Department of Urology, Regional Hospital Randers	Randers	Denmark
Department of Urology, Regional Hospital Viborg	Viborg	Denmark

More Aarhus University Hospital trials in Denmark

Clinical Utility of ctDNA in the Treatment of Oligometastatic Disease Starting soon

Medial Patellofemoral Ligament Reconstruction in Children - a 2-8 Years Follow-up Study Active, not recruiting

Radical Surgery for Advanced Gastric- or GEJ-cancer With Oligometastatic Dissmination to the Liver Recruiting

Selective Internal Radiation Therapy With 90Y Resin Micropheres for Refractory Colorectal Cancer Liver Metastases Recruiting

Thyroid Nodule Gene Sequencing in a Danish Population Active, not recruiting

Other trials for the same condition

REtrieval of Transurethrally Resected Intact En-bloc Vesical Tumors Using a Retrieval Device for Bladder Tumors Starting soon

Supporting Sexual Health in Bladder Cancer Patients: A Sequential Mixed-Methods Intervention Study Recruiting

Study of bladdeR Cancer Detection in Standard White Light Versus AI-Supported Endoscopy-02 Enrolling by invitation

Comprehensive Geriatric Assessment for Perioperative Optimization in Cystectomy Recruiting

Treatment Of Metastatic Bladder Cancer at the Time Of Biochemical reLApse Following Radical Cystectomy Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05195515 on ClinicalTrials.gov ↗ ← All trials in Denmark